Keywords: orion, simdax, gets, mixed, eu, opinion, pharma

Orion's Simdax gets mixed EU opinion

Article | 17 April 2001

Orion Pharma has received favorable mutual recognition decisions forits acute heart failure treatment, Simdax (levosimendan), which has been on the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Abbott

Abbott Laboratories

Orion Pharma

Go to company listing